Loading…
COMPASS Pathways plc is projected to rise to $17.37 by 2027, a +53% move from its current price of $11.35. CMPS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $10.97 | $11.35 | $11.75 | +0.03% |
| Aug 3 | $10.82 | $11.36 | $11.92 | +0.06% |
| Aug 4 | $10.71 | $11.36 | $12.05 | +0.09% |
| Aug 5 | $10.61 | $11.36 | $12.17 | +0.12% |
| Aug 6 | $10.53 | $11.37 | $12.27 | +0.15% |
| Aug 7 | $10.45 | $11.37 | $12.37 | +0.18% |
| Aug 8 | $10.39 | $11.37 | $12.45 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.39 | $11.37 | $12.45 | +0.21% |
| Week 2 | $10.03 | $11.40 | $12.96 | +0.42% |
| Week 3 | $9.76 | $11.42 | $13.36 | +0.62% |
| Week 4 | $9.55 | $11.44 | $13.72 | +0.83% |
| Week 5 | $9.36 | $11.47 | $14.05 | +1.04% |
| Week 6 | $9.20 | $11.49 | $14.35 | +1.25% |
| Week 7 | $9.06 | $11.52 | $14.64 | +1.46% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa.
The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
COMPASS Pathways plc (CMPS) is currently priced at $11.26. The asset sits in a biotechnology/h ealthcare sector focus with mental health as a primary aim, and trades with a current price of $11.26.
Its market cap is $1.52B and it ranks 2097. The company’s position reflects a relatively small capitalization within the broader market, with a listed rank of 2097.
The overall price outlook is bullish over the long term, with forecasts showing upside through the coming years. The forecasted averages begin at $11.26 for 2026 and rise to higher levels in subsequent years, including $17.60 in 2027, $27.99 in 2030, and $238.86 in 2050, with a range of projected max values up to $497.05 by 2050.
Forecasts also show rising ROI over time, including 56.3% in 2027, 148.5% in 2030, and 2021.3% in 2050, all with a bullish sentiment attached.
A major floor 54.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.4% below — buyers have tended to step in here.
The nearest ceiling, 32.8% above — a clean break opens room to run.
A major ceiling 46.6% above — clearing it would confirm fresh momentum.
Key CMPS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CMPS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.19 | Buy | $11.33 | Buy |
| MA 10 | $11.47 | Sell | $11.58 | Sell |
| MA 20 | $12.32 | Sell | $12.00 | Sell |
| MA 50 | $12.45 | Sell | $11.79 | Sell |
| MA 100 | $9.97 | Buy | $10.58 | Buy |
| MA 200 | $8.23 | Buy | $8.92 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.72 | Neutral |
| Stoch RSI (14) | 35.26 | Neutral |
| CCI (20) | -75.99 | Neutral |
| Williams %R (14) | -80.31 | Info |
| MACD (12,26,9) | -0.18 | Sell |
| ROC (12) | -14.73 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 19.69 | Buy |
| TRIX (15) | -0.26 | Sell |
| Awesome (5,34) | -1.42 | Sell |
| Ultimate (7,14,28) | 35.58 | Neutral |
| Momentum (10) | -1.00 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 11.09 | Buy |
| ADX (14) | 16.64 | Neutral |
| ATR (14) | 0.39 | Info |
The 30-day technical picture is bullish overall, with near-term momentum supported by the current price action.
RSI14 is 40, indicating room to move before overbought conditions develop. The short-term moving averages show SMA50 at $12.35 and SMA200 at $8.09, painting a gradually improving trend as prices move.
The price approach is toward support at $11.03 with resistance at $15.07. The 30-day trading range spans $8.85 to $14.33, and the current price sits near the lower end of that range at $11.26.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.22 | $11.35 | $15.00 | 0% | Neutral | |
| $13.53 | $17.37 | $23.76 | +53% | Bullish | |
| $16.44 | $21.89 | $31.33 | +93% | Bullish | |
| $18.43 | $25.29 | $37.50 | +123% | Bullish | |
| $19.57 | $27.58 | $42.12 | +143% | Bullish | |
| $22.30 | $32.22 | $50.47 | +184% | Bullish | |
| $25.08 | $37.08 | $59.42 | +227% | Bullish | |
| $28.34 | $42.82 | $70.04 | +277% | Bullish | |
| $37.67 | $58.10 | $96.84 | +412% | Bullish | |
| $42.43 | $66.76 | $113.22 | +488% | Bullish | |
| $64.75 | $111.65 | $203.55 | +884% | Bullish | |
| $118.40 | $240.41 | $486.31 | +20.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.22 | $11.35 | $13.69 | +0.00% |
| September 2026 | $9.38 | $11.18 | $13.76 | -1.50% |
| October 2026 | $9.70 | $11.66 | $14.55 | +4.30% |
| November 2026 | $9.87 | $11.96 | $15.07 | +2.53% |
| December 2026 | $9.67 | $11.78 | $15.00 | -1.44% |
Click any year to see its month-by-month CMPS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CMPS price prediction for 2026 points to an average of $11.35 (low $5.22, high $15.00) — a potential gain of 0% on today's $11.35. Price action looks broadly range-bound.
In 2027, CMPS is projected to trade between $13.53 and $23.76, averaging $17.37 — a potential gain of +53% from today's $11.35. That is up +53% on the projected 2026 average. Buyers look set to stay in control over this stretch.
COMPASS Pathways plc's 2028 outlook centres on $21.89, within a $16.44 to $31.33 range. That is up +26% on the projected 2027 average. That marks a +93% change versus current levels. Momentum favours further upside here.
By 2029, CMPS could reach as high as $37.50, with a base case around $25.29 and support toward $18.43 — roughly +123% from $11.35. Buyers look set to stay in control over this stretch.
Expect CMPS to range from $19.57 to $42.12 through 2030. The $27.58 average target implies a +143% move from current prices. That is up +9% on the projected 2029 average. Momentum favours further upside here.
The CMPS price prediction for 2031 points to an average of $32.22 (low $22.30, high $50.47) — a potential gain of +184% on today's $11.35. Buyers look set to stay in control over this stretch.
In 2032, CMPS is projected to trade between $25.08 and $59.42, averaging $37.08 — a potential gain of +227% from today's $11.35. That is up +15% on the projected 2031 average. Momentum favours further upside here.
COMPASS Pathways plc's 2033 outlook centres on $42.82, within a $28.34 to $70.04 range. That is up +15% on the projected 2032 average. That marks a +277% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, CMPS could reach as high as $96.84, with a base case around $58.10 and support toward $37.67 — roughly +412% from $11.35. Momentum favours further upside here.
Expect CMPS to range from $42.43 to $113.22 through 2035. The $66.76 average target implies a +488% move from current prices. That is up +15% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The CMPS price prediction for 2040 points to an average of $111.65 (low $64.75, high $203.55) — a potential gain of +884% on today's $11.35. Momentum favours further upside here.
In 2050, CMPS is projected to trade between $118.40 and $486.31, averaging $240.41 — a potential gain of +20.2x from today's $11.35. That is up +115% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CMPS today (≈ 88.105727 CMPS) could be worth
$21,181.19
+$20,181.19 (+2018%) by 2050 · US Dollar
Based on the average projected CMPS price of $240.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CMPSwould be worth at today's price.
$1,000 invested in CMPS on Jul 31, 2025 (≈ 229.885063 CMPS) would be worth
$2,609.2
+$1,609.2 (+160.9%) today · 2.61× · US Dollar
Based on a CMPS entry price of $4.35 vs. today's $11.35.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.26 | $1,007.99 | +0.8% |
| 1 month ago | $13.29 | $854.03 | -14.6% |
| 3 months ago | $9.01 | $1,259.71 | +26.0% |
| 6 months ago | $6.61 | $1,717.1 | +71.7% |
| 1 year ago | $4.35 | $2,609.2 | +160.9% |
| All time (5.0y) ago | $33.94 | $334.41 | -66.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CMPS forecast.
Our base-case forecast reaches $23.00 around 2029.
Implied market cap at $23.00: $3.1B
The multi-year forecast implies meaningful upside across the long horizon. By 2030, the average price is forecast at $27.99 with a max of $43.44 and a min of $19.54, yielding an ROI of 148.5% and a bullish sentiment. By 2040, the average price is forecast at $109.66 with a max of $204.84 and a min of $61.45, yielding an ROI of 873.9% and a bullish sentiment.
By 2050, the average price is forecast at $238.86 with a max of $497.05 and a min of $111.57, yielding an ROI of 2021.3% and a bullish sentiment.
The trajectory from 2027 onward shows continuing upside, with 2027 avg $17.60, 2028 avg $21.93, 2029 avg $25.24, and 2031–2035 rising to the $32.04–$67.03 range before accelerating toward the 2040 and 2050 milestones. These figures illustrate a long-run bullish outlook, balanced by the inherent uncertainty of clinical and regulatory developments in the biotechnology space.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $27.99, with a minimum of $19.54 and a maximum of $43.44, and a predicted ROI of 148.5% with a bullish sentiment.
Forecasts indicate a bullish sentiment from 2027 onward, with rising averages: 2027 $17.60, 2028 $21.93, 2029 $25.24, 2030 $27.99, 2040 $109.66, and 2050 $238.86, along with notable ROI figures (e.g., 56.3% in 2027, 148.5% in 2030, 2021.3% in 2050). These are estimates, not guarantees.
Yes, based on the forecasted max values, CMPS could surpass $60 in a higher-max scenario: 2032 max is $59.68 and 2033 max is $70.79, with the latter exceeding $60.
The 30-day range is $8.85 to $14.33. The current price is $11.26, with support at $11.03 and resistance at $15.07. RSI is 40, SMA50 is $12.35, and SMA200 is $8.09.
The 2050 forecast shows an average price of $238.86, a minimum of $111.57, a maximum of $497.05, and an ROI of 2021.3%, with a bullish sentiment.
COMPASS Pathways plc Community Discussion
0Share your COMPASS Pathways plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.